Know Cancer

or
forgot password

    • cancer clinical trials in laconia, NH

    • Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Lung Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Breast Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Brain and Central Nervous System Tumors
    Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Brain and Central Nervous System Tumors
    Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Colorectal Cancer, Precancerous Condition
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Breast Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Kidney Cancer
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Breast Cancer, Depression, Fatigue, Sleep Disorders
    S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
    LRGHealthcare-Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Prostate Cancer
    Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Breast Cancer, Osteoporosis
    Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Anemia, Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Neutropenia
    Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue, Metastatic Cancer, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity
    Vitamin D and Breast Cancer Biomarkers in Female Patients
    Lakes Region General Hospital
    Laconia, New Hampshire 03246
    Breast Cancer